FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Renée Blosser-Middleton

Research Profile

Procedures

Living Beings

Chemicals & Drugs

Physiology

Disorders

Geographic Areas

Co-author Network

Publications

TOP 3
Caio Mendes; Carlos R V Kiffer; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky; A Barth; F Rossi; S Andrade; Helio S Sader; Clyde Thornsberry; Daniel F Sahm
Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.
Yigong Ge; Matthew A Wikler; Daniel F Sahm; Renée S Blosser-Middleton; James A Karlowsky
In vitro antimicrobial activity of doripenem, a new carbapenem.
Mark E Jones; Renée S Blosser-Middleton; Clyde Thornsberry; James A Karlowsky; Daniel F Sahm
The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Renée Blosser-Middleton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Caio Mendes; Carlos R V Kiffer; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky; A Barth; F Rossi; S Andrade; Helio S Sader; Clyde Thornsberry; Daniel F Sahm
Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(6):521-6.
2004: Yigong Ge; Matthew A Wikler; Daniel F Sahm; Renée S Blosser-Middleton; James A Karlowsky
In vitro antimicrobial activity of doripenem, a new carbapenem.
Antimicrobial agents and chemotherapy 2004;48(4):1384-96.
2003: Mark E Jones; Renée S Blosser-Middleton; Clyde Thornsberry; James A Karlowsky; Daniel F Sahm
The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.
Diagnostic microbiology and infectious disease 2003;47(4):579-86.
2003: Mark E Jones; Renée S Blosser-Middleton; Ian A Critchley; James A Karlowsky; Clyde Thornsberry; Daniel F Sahm
In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(7):590-9.
2003: Renée S Blosser-Middleton; Daniel F Sahm; Clyde Thornsberry; Mark E Jones; P A Hogan; Ian A Critchley; James A Karlowsky
Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(5):431-6.
2003: Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; Clyde Thornsberry; Daniel F Sahm; James A Karlowsky
Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001.
Antimicrobial agents and chemotherapy 2003;47(5):1689-93.
2003: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Elena Karginova; Clyde Thornsberry; Daniel F Sahm
Reinterpretation of susceptibility data using current NCCLS breakpoint criteria.
Antimicrobial agents and chemotherapy 2003;47(2):830.
2003: Mark E Jones; Renée S Blosser-Middleton; Ian A Critchley; James A Karlowsky; Clyde Thornsberry; Daniel F Sahm
Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
The Journal of antimicrobial chemotherapy 2003;51(1):196-9.
2002: Mark E Jones; Renée S Blosser-Middleton; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm; Juri Yamakita; Moriaki Akasaki; James A Karlowsky
The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000.
Chemotherapy 2002;48(5):232-7.
2002: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm
Relationship between antibiotic resistance in Streptococcus pneumoniae and that in Haemophilus influenzae: evidence for common selective pressure.
Antimicrobial agents and chemotherapy 2002;46(9):3106-7.
2002: Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky; Elena Karginova; Clyde Thornsberry; Daniel F Sahm
Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.
International journal of antimicrobial agents 2002;20(2):100-7.
2002: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Elena Karginova; Clyde Thornsberry; Daniel F Sahm
Longitudinal assessment of antipneumococcal susceptibility in the United States.
Antimicrobial agents and chemotherapy 2002;46(8):2651-5.
2002: Mark E Jones; Ian A Critchley; James A Karlowsky; Renée S Blosser-Middleton; Franz-Josef Schmitz; Clyde Thornsberry; Daniel F Sahm
In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.
Antimicrobial agents and chemotherapy 2002;46(6):1651-7.
2002: Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; Juri Yamakita; N Aswapokee; Pantip Chayakul; P Tharavichitukul; A Vibhagool; Clyde Thornsberry; James A Karlowsky; Daniel F Sahm
Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.
Journal of chemotherapy (Florence, Italy) 2002;14(2):147-54.
2002: James A Karlowsky; Ian A Critchley; Renée S Blosser-Middleton; Elena Karginova; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.
Journal of clinical microbiology 2002;40(3):1063-6.
2002: Ian A Critchley; Daniel F Sahm; Clyde Thornsberry; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky
Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999.
Diagnostic microbiology and infectious disease 2002;42(2):129-35.
2002: Mark E Jones; James A Karlowsky; Renée S Blosser-Middleton; Ian A Critchley; Clyde Thornsberry; Daniel F Sahm
Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.
International journal of antimicrobial agents 2002;19(2):119-23.